May 2016
RoundTable Healthcare Partners Announces Sale of the Topical Pharmaceutical Division of Renaissance Acquisition Holdings, LLC
LAKE FOREST, IL, May 13, 2016 — RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the health-care industry, announced today that its portfolio company Renaissance Acquisition Holdings, LLC (“Renaissance”) has entered into a definitive agreement to sell its topical pharmaceutical business (the “Topical Division”) to Mylan N.V. (“Mylan”), a leading, global generic and specialty pharmaceutical company, for $950 million in cash at closing, plus additional contingent payments of up to $50 million, subject to customary adjustments. The closing is conditional on regulatory approval and other customary closing conditions.